Gemtesa 75 MG tablet 90S
Ended Awarded
- Contract number
- SPE2DB26FDSUR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $86,421
Award facts
- Contract value 100% obligated
- $86,421.37 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $86,421.37 to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for October 29, 2025, and fulfillment occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999.99 billion global pharmaceutical support vehicle extending through December 2026 that enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio with the Defense Logistics Agency demonstrates consistent capability in fulfilling federal medical procurement requirements through open competition, with delivery orders spanning diverse therapeutic domains including specialty medications, vaccines, and medical devices. This particular order for Gemtesa, a medication used in urological treatment, reflects the vendor's established role as a primary supplier of both brand-name and generic pharmaceuticals within the federal military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB26FDSUR?
SPE2DB26FDSUR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FDSUR worth?
The government has obligated $86,421 on SPE2DB26FDSUR.
Is contract SPE2DB26FDSUR an order under another contract?
Yes. SPE2DB26FDSUR is a delivery order under SPE2DB24D2205, an indefinite delivery contract.
Was contract SPE2DB26FDSUR competed?
The extent of competition for SPE2DB26FDSUR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award